Three decades of progress in treating childhood-onset lupus nephritis (Q35983508)

11 August 2017

Three decades of progress in treating childhood-onset lupus nephritis (English)

1 reference

11 August 2017

Tanya Pereira

1

1 reference

11 August 2017

Carolyn L Abitbol

2

1 reference

11 August 2017

Wacharee Seeherunvong

3

1 reference

11 August 2017

Chryso Katsoufis

4

1 reference

11 August 2017

Jayanthi Chandar

5

1 reference

11 August 2017

Michael Freundlich

6

1 reference

11 August 2017

Gastón Zilleruelo

7

1 reference

11 August 2017

28 July 2011

1 reference

Clinical Journal of the American Society of Nephrology

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

9

1 reference

11 August 2017

2192-2199

1 reference

Increased risk of death in pediatric and adult patients with ESRD secondary to lupus

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Childhood- and adult-onset lupus: an update of similarities and differences.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Evaluation of C1q genomic region in minority racial groups of lupus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Rituximab therapy for juvenile-onset systemic lupus erythematosus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Treatment of lupus nephritis in children

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Intravenous cyclophosphamide therapy of severe SLE.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Ethnic differences in pediatric systemic lupus erythematosus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Outcomes in African Americans and Hispanics with lupus nephritis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Infection in children with lupus nephritis receiving pulse and oral cyclophosphamide therapy

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

A functional immature model of chronic partial ureteral obstruction

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Sequential therapies for proliferative lupus nephritis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Longterm followup of childhood lupus nephritis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3359002

Prognosis of lupus membranous nephritis in children

24 September 2018

1 reference

12 December 2020

Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only

1 reference

12 December 2020

B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus

1 reference

12 December 2020

Outcomes of children with proliferative lupus nephritis: the role of protocol renal biopsy

1 reference

12 December 2020

Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis?

1 reference

12 December 2020

Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis

1 reference

12 December 2020

Profiling proteinuria in pediatric patients

1 reference

12 December 2020

Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis

1 reference

12 December 2020

The classification of glomerulonephritis in systemic lupus erythematosus revisited

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

12 December 2020

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

1 reference

12 December 2020

Identifiers

DOI

10.2215/CJN.00910111

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

21799148

1 reference